December 3, 2020 – McKesson Corporation announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer.
Building on McKesson’s long history in community oncology, Ontada combines its real-world data and research capabilities with a leading suite of technologies for oncology clinicians – including the iKnowMed electronic health record (EHR)system and Clear Value Plus regimen support tool – as well as a connection to a national community oncology network to transform the fight against cancer.
McKesson says that Ontada is uniquely positioned to advance cancer care by enabling deep collaboration between life sciences companies and oncology providers. Its team of data scientists and oncology experts help life sciences companies leverage evidence-based data and insights to accelerate innovation and improve cancer therapy, while empowering providers to deliver the best care and improved outcomes for patients. Ontada will provide a number of real clinical benefits to enable life sciences companies to help bring breakthrough oncology products to market sooner and better support the entire patient journey.
Through its deep connections to oncology practices, Ontada can help expand the reach of therapies with engagement and education opportunities with physicians. The benefits that Ontada can offer to providers are further enhanced through its strong relationship with McKesson’s The US Oncology Network, as well as other community oncology practices.